Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France).

BMC Med Genomics. 2018 Mar 6;11(1):23. doi: 10.1186/s12920-018-0338-x.

2.

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.

Danion P, Buisson A, Roblin X, Mathieu N, Charlois AL, Borgerding JN, Williet N, Del Tedesco E, Flourié B, Nancey S, Boschetti G.

Inflamm Bowel Dis. 2018 Apr 23;24(5):943-952. doi: 10.1093/ibd/izx073.

PMID:
29506217
3.

How to strengthen the presence of patients in health technology assessments conducted by the health authorities.

Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII, Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N.

Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. French.

PMID:
29478707
4.

Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.

Mak WY, Buisson A, Andersen MJ Jr, Lei D, Pekow J, Cohen RD, Kahn SA, Pereira B, Rubin DT.

Dig Dis Sci. 2018 May;63(5):1294-1301. doi: 10.1007/s10620-018-4980-0. Epub 2018 Feb 22.

PMID:
29468374
5.

Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.

Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A.

World J Gastroenterol. 2018 Feb 7;24(5):641-650. doi: 10.3748/wjg.v24.i5.641.

6.

Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.

Huguet M, Pereira B, Goutte M, Goutorbe F, Dubois A, Bommelaer G, Buisson A.

Inflamm Bowel Dis. 2018 Jan 18;24(2):261-268. doi: 10.1093/ibd/izx049.

PMID:
29361101
7.

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

D'Haens G, Vermeire S, Lambrecht G, Baert F, Bossuyt P, Pariente B, Buisson A, Bouhnik Y, Filippi J, Vander Woude J, Van Hootegem P, Moreau J, Louis E, Franchimont D, De Vos M, Mana F, Peyrin-Biroulet L, Brixi H, Allez M, Caenepeel P, Aubourg A, Oldenburg B, Pierik M, Gils A, Chevret S, Laharie D; GETAID.

Gastroenterology. 2018 Apr;154(5):1343-1351.e1. doi: 10.1053/j.gastro.2018.01.004. Epub 2018 Jan 6.

PMID:
29317275
8.

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Aliment Pharmacol Ther. 2018 Mar;47(5):588-595. doi: 10.1111/apt.14487. Epub 2018 Jan 8.

PMID:
29315694
9.

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A; GETAID OBSERV-IBD study group.

Aliment Pharmacol Ther. 2018 Feb;47(4):485-493. doi: 10.1111/apt.14419. Epub 2017 Dec 18.

PMID:
29250803
10.

Predictive performance of four frailty screening tools in community-dwelling elderly.

Bongue B, Buisson A, Dupre C, Beland F, Gonthier R, Crawford-Achour É.

BMC Geriatr. 2017 Nov 10;17(1):262. doi: 10.1186/s12877-017-0633-y.

11.

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

Labidi-Galy SI, Olivier T, Rodrigues M, Ferraioli D, Derbel O, Bodmer A, Petignat P, Rak B, Chopin N, Tredan O, Heudel PE, Stuckelberger S, Meeus P, Meraldi P, Viassolo V, Ayme A, Chappuis PO, Stern MH, Houdayer C, Stoppa-Lyonnet D, Buisson A, Golmard L, Bonadona V, Ray-Coquard I.

Clin Cancer Res. 2018 Jan 15;24(2):326-333. doi: 10.1158/1078-0432.CCR-17-2136. Epub 2017 Oct 30.

PMID:
29084914
12.

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Collins M, Michot JM, Danlos FX, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin AL, Soria JC, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Nov 1;28(11):2860-2865. doi: 10.1093/annonc/mdx403.

PMID:
29045560
13.

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.

Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, Pineton de Chambrun G, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H; Goli-Crohn Study Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1077-1084. doi: 10.1111/apt.14371. Epub 2017 Oct 13.

PMID:
29027693
14.

GluN2B Subunit Labeling with Fluorescent Probes and High-Resolution Live Imaging.

Perrio C, Nicole O, Buisson A.

Methods Mol Biol. 2017;1677:171-183. doi: 10.1007/978-1-4939-7321-7_9.

PMID:
28986873
15.

Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn's disease.

Buisson A, Pereira B, Goutte M, Reymond M, Allimant C, Obritin-Guilhen H, Bommelaer G, Hordonneau C.

Dig Liver Dis. 2017 Nov;49(11):1211-1217. doi: 10.1016/j.dld.2017.08.033. Epub 2017 Aug 31.

PMID:
28919192
16.

Involvement of CRF2 signaling in enterocyte differentiation.

Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M.

World J Gastroenterol. 2017 Jul 28;23(28):5127-5145. doi: 10.3748/wjg.v23.i28.5127.

17.

Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's Disease.

Buisson A, Hordonneau C, Deepak P.

Inflamm Bowel Dis. 2017 Sep;23(9):E44-E45. doi: 10.1097/MIB.0000000000001219. No abstract available.

PMID:
28786868
18.

Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

J Clin Gastroenterol. 2018 Aug;52(7):e53-e62. doi: 10.1097/MCG.0000000000000837.

PMID:
28723856
19.

TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid-β peptide.

Bosson A, Paumier A, Boisseau S, Jacquier-Sarlin M, Buisson A, Albrieux M.

Mol Neurodegener. 2017 Jul 6;12(1):53. doi: 10.1186/s13024-017-0194-8.

20.

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Gagniere C, Bouhnik Y; OBSERV-IBD study group and the GETAID.

Aliment Pharmacol Ther. 2017 Aug;46(3):310-321. doi: 10.1111/apt.14167. Epub 2017 Jun 8.

PMID:
28593685
21.

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.

Buisson A, Gonzalez F, Poullenot F, Nancey S, Sollellis E, Fumery M, Pariente B, Flamant M, Trang-Poisson C, Bonnaud G, Mathieu S, Thevenin A, Duruy M, Filippi J, Lʼhopital F, Luneau F, Michalet V, Genès J, Achim A, Cruzille E, Bommelaer G, Laharie D, Peyrin-Biroulet L, Pereira B, Nachury M, Bouguen G; ACCEPT study group.

Inflamm Bowel Dis. 2017 Aug;23(8):1425-1433. doi: 10.1097/MIB.0000000000001140.

PMID:
28570431
22.

Nasal high flow in management of children with status asthmaticus: a retrospective observational study.

Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E.

Ann Intensive Care. 2017 Dec;7(1):55. doi: 10.1186/s13613-017-0278-1. Epub 2017 May 22.

23.

Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study.

Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A.

Eur J Pain. 2017 Oct;21(9):1550-1560. doi: 10.1002/ejp.1056. Epub 2017 May 16.

PMID:
28508514
24.

The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation.

Amar F, Sherman MA, Rush T, Larson M, Boyle G, Chang L, Götz J, Buisson A, Lesné SE.

Sci Signal. 2017 May 9;10(478). pii: eaal2021. doi: 10.1126/scisignal.aal2021.

25.

Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Campos C, Perrey A, Lambert C, Pereira B, Goutte M, Dubois A, Goutorbe F, Dapoigny M, Bommelaer G, Hordonneau C, Buisson A.

Dig Dis Sci. 2017 Jun;62(6):1628-1636. doi: 10.1007/s10620-017-4572-4. Epub 2017 Apr 11.

PMID:
28401425
26.

Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X.

J Crohns Colitis. 2017 Aug 1;11(8):930-935. doi: 10.1093/ecco-jcc/jjx027.

PMID:
28333202
27.

What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?

Buisson A, Hordonneau C, Goutte M, Bommelaer G.

J Gastroenterol. 2017 May;52(5):652-653. doi: 10.1007/s00535-016-1301-2. Epub 2016 Dec 29. No abstract available.

PMID:
28035486
28.

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, Jouven X, Treton X, Allez M; REMIND study group investigators.

Am J Gastroenterol. 2017 Feb;112(2):337-345. doi: 10.1038/ajg.2016.541. Epub 2016 Dec 13.

PMID:
27958285
29.

Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease.

Buisson A, Bringer MA, Barnich N, Vazeille E.

Inflamm Bowel Dis. 2016 Dec;22(12):2943-2955. Review.

PMID:
27824652
30.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

PMID:
26917043
31.

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.

32.

Ultrafast Singlet Energy Transfer in Porphyrin Dyads.

Dekkiche H, Buisson A, Langlois A, Karsenti PL, Ruhlmann L, Harvey PD, Ruppert R.

Inorg Chem. 2016 Oct 6. [Epub ahead of print]

PMID:
27709919
33.

Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients.

Williet N, Sarter H, Gower-Rousseau C, Adrianjafy C, Olympie A, Buisson A, Beaugerie L, Peyrin-Biroulet L.

J Crohns Colitis. 2017 Feb;11(2):165-174. doi: 10.1093/ecco-jcc/jjw145. Epub 2016 Aug 11.

PMID:
27516406
34.

Metal Linkage Effects on Ultrafast Energy Transfer.

Dekkiche H, Buisson A, Langlois A, Karsenti PL, Ruhlmann L, Ruppert R, Harvey P.

Chemistry. 2016 Jul 18;22(30):10484-93. doi: 10.1002/chem.201601322. Epub 2016 Jun 22.

PMID:
27333487
35.

Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's disease.

Boucher AL, Pereira B, Decousus S, Goutte M, Goutorbe F, Dubois A, Gagniere J, Borderon C, Joubert J, Pezet D, Dapoigny M, Déchelotte PJ, Bommelaer G, Buisson A.

World J Gastroenterol. 2016 Jun 7;22(21):5068-78. doi: 10.3748/wjg.v22.i21.5068.

36.

Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease.

Decousus S, Boucher AL, Joubert J, Pereira B, Dubois A, Goutorbe F, Déchelotte PJ, Bommelaer G, Buisson A.

Dig Liver Dis. 2016 Jul;48(7):753-8. doi: 10.1016/j.dld.2016.02.023. Epub 2016 Mar 3.

PMID:
27005857
37.

Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

Aliment Pharmacol Ther. 2016 May;43(10):1069-79. doi: 10.1111/apt.13585. Epub 2016 Mar 8.

38.

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N, Altwegg R, Buisson A, Cazelles-Boudier C, Racine A, Vergniol J, Laharie D; le GETAID.

Inflamm Bowel Dis. 2016 Jun;22(6):1362-9. doi: 10.1097/MIB.0000000000000741.

PMID:
26919458
39.

Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.

Buisson A, Hordonneau C, Goutte M, Scanzi J, Goutorbe F, Klotz T, Boyer L, Pereira B, Bommelaer G.

Dig Liver Dis. 2016 Mar;48(3):260-6. doi: 10.1016/j.dld.2015.10.019. Epub 2015 Nov 22.

PMID:
26699828
40.

GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.

Vazeille E, Chassaing B, Buisson A, Dubois A, de Vallée A, Billard E, Neut C, Bommelaer G, Colombel JF, Barnich N, Darfeuille-Michaud A, Bringer MA.

Inflamm Bowel Dis. 2016 Jan;22(1):68-81. doi: 10.1097/MIB.0000000000000609.

PMID:
26512715
41.

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):242-50.e1-2. doi: 10.1016/j.cgh.2015.09.018. Epub 2015 Sep 30.

42.

Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.

Goutorbe F, Goutte M, Minet-Quinard R, Boucher AL, Pereira B, Bommelaer G, Buisson A.

J Crohns Colitis. 2015 Dec;9(12):1113-9. doi: 10.1093/ecco-jcc/jjv150. Epub 2015 Sep 7.

PMID:
26351383
43.

Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.

Buisson A, Hordonneau C, Goutte M, Boyer L, Pereira B, Bommelaer G.

Aliment Pharmacol Ther. 2015 Aug;42(4):452-60. doi: 10.1111/apt.13287. Epub 2015 Jun 18.

44.

Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.

Fumery M, Pineton de Chambrun G, Stefanescu C, Buisson A, Bressenot A, Beaugerie L, Amiot A, Altwegg R, Savoye G, Abitbol V, Bouguen G, Simon M, Duffas JP, Hébuterne X, Nancey S, Roblin X, Leteurtre E, Bommelaer G, Lefevre JH, Brunetti F, Guillon F, Bouhnik Y, Peyrin-Biroulet L.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1770-5. doi: 10.1016/j.cgh.2015.04.185. Epub 2015 May 19.

45.

What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?

Buisson A, Hordonneau C, Goutte M, Bommelaer G.

Inflamm Bowel Dis. 2015 Jun;21(6):E9. doi: 10.1097/MIB.0000000000000415. No abstract available.

46.

Insights into the relationship between the proteasome and autophagy in human and yeast cells.

Athané A, Buisson A, Challier M, Beaumatin F, Manon S, Bhatia-Kiššová I, Camougrand N.

Int J Biochem Cell Biol. 2015 Jul;64:167-73. doi: 10.1016/j.biocel.2015.04.002. Epub 2015 Apr 13.

PMID:
25882491
47.

Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.

Duron C, Goutte M, Pereira B, Bommelaer G, Buisson A.

Eur J Gastroenterol Hepatol. 2015 Jun;27(6):705-11. doi: 10.1097/MEG.0000000000000354.

PMID:
25856689
48.

Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.

Vazeille E, Buisson A, Bringer MA, Goutte M, Ouchchane L, Hugot JP, de Vallée A, Barnich N, Bommelaer G, Darfeuille-Michaud A.

J Crohns Colitis. 2015 May;9(5):410-20. doi: 10.1093/ecco-jcc/jjv053. Epub 2015 Mar 24.

PMID:
25805890
49.

Disruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata.

Bosson A, Boisseau S, Buisson A, Savasta M, Albrieux M.

Glia. 2015 Apr;63(4):673-83. doi: 10.1002/glia.22777. Epub 2014 Dec 15.

PMID:
25511180
50.

An uncommon complication of chronic antibiotics refractory pouchitis after ileal pouch-anal anastomosis for ulcerative colitis.

Goutorbe F, Buisson A, Bommelaer G.

Gastroenterology. 2014 Oct;147(4):743-4. doi: 10.1053/j.gastro.2014.04.050. Epub 2014 Aug 23. No abstract available.

PMID:
25158030

Supplemental Content

Loading ...
Support Center